start portlet menu bar end portlet menu bar

1. What is atrophic rhinitis?

Hjem Viden 1. What is atrophic rhinitis?

1. What is atrophic rhinitis?


Atrophic Rhinitis (AR) is present in every country where there is pig production, and it has two presentations: Progressive Atrophic Rhinitis (PAR) in fattening pigs, which is caused by Pasteurella multocida type D, and Non-Progressive Atrophic Rhinitis (NPAR) in nursery pigs, which is produced by Bordetella bronchiseptica.

Download denne artikel

1,63 MB

Om denne artikel

Forfattere

Swine Business Unit, HIPRA

Resume

Although you may think that your pigs are not affected by AR, this disease is still present in almost all swine herds, its prevalence increasing because of the reduction in the use of antibiotics. This is why it is essential to understand the disease, to monitor it on your farms by oral fluid diagnosis and nasal lesion evaluation, and to prevent it by vaccinating sows and protecting all the piglets with maternal immunity.

Lignende produkter

RHINISENG®

Lignende publikationer

2. What is the role of Bordetella bronchiseptica in Swine respiratory diseases? 3. How to diagnose atrophic rhinitis? 4. What are the economic losses caused by atrophic rhinitis?

Del

The contents of this page are country specific and aimed specifically at prescribing veterinarians.

This product is not available in {{ preferredCountry.title }}.

You will be redirected to our global site. Click on continue to visit our global site (available in English).

Confirm that you are a veterinary professional:

This product is not available in {{ countrySelect.title }}.

You will be redirected to our global site. Click on continue to visit our global site (available in English).

  • I am a veterinarian (otherwise please contact a veterinary professional)

Select your country:

Country {{countrySelect.title}}
  • Global (available in English)
  • {{country.title}}
start portlet menu bar

Atrophic Rhinitis in pigs: What are the clinical signs?

Display portlet menu
end portlet menu bar

Se også

Publikationer

Efficacy of a new inactivated vaccine against Chlamydia abortus and Salmonella enterica se...

23-09-2019
Sygdom kort

Control of MYCOPLASMA HYOPNEUMONIAE by serological monitoring

22-05-2019
Nyheder

Vi har udviklet os for at blive stærkere

23-06-2021